NM_001283009.2:c.2112C>T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001283009.2(RTEL1):​c.2112C>T​(p.Asp704Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0818 in 1,610,866 control chromosomes in the GnomAD database, including 6,074 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 419 hom., cov: 33)
Exomes 𝑓: 0.083 ( 5655 hom. )

Consequence

RTEL1
NM_001283009.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 0.634
Variant links:
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 20-63689836-C-T is Benign according to our data. Variant chr20-63689836-C-T is described in ClinVar as [Benign]. Clinvar id is 403399.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-63689836-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.634 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTEL1NM_001283009.2 linkc.2112C>T p.Asp704Asp synonymous_variant Exon 24 of 35 ENST00000360203.11 NP_001269938.1 Q9NZ71-6R4IXY3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTEL1ENST00000360203.11 linkc.2112C>T p.Asp704Asp synonymous_variant Exon 24 of 35 5 NM_001283009.2 ENSP00000353332.5 Q9NZ71-6
RTEL1ENST00000508582.7 linkc.2184C>T p.Asp728Asp synonymous_variant Exon 24 of 35 2 ENSP00000424307.2 Q9NZ71-7
RTEL1ENST00000370018.7 linkc.2112C>T p.Asp704Asp synonymous_variant Exon 24 of 35 1 ENSP00000359035.3 Q9NZ71-1
RTEL1-TNFRSF6BENST00000492259.6 linkn.2196C>T non_coding_transcript_exon_variant Exon 22 of 35 5 ENSP00000457428.1 D6RA96

Frequencies

GnomAD3 genomes
AF:
0.0666
AC:
10130
AN:
152142
Hom.:
420
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0165
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0796
Gnomad ASJ
AF:
0.114
Gnomad EAS
AF:
0.00193
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.0809
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.0904
Gnomad OTH
AF:
0.0842
GnomAD3 exomes
AF:
0.0791
AC:
19445
AN:
245828
Hom.:
1007
AF XY:
0.0845
AC XY:
11317
AN XY:
133910
show subpopulations
Gnomad AFR exome
AF:
0.0130
Gnomad AMR exome
AF:
0.0572
Gnomad ASJ exome
AF:
0.120
Gnomad EAS exome
AF:
0.000273
Gnomad SAS exome
AF:
0.120
Gnomad FIN exome
AF:
0.0850
Gnomad NFE exome
AF:
0.0914
Gnomad OTH exome
AF:
0.0959
GnomAD4 exome
AF:
0.0834
AC:
121616
AN:
1458606
Hom.:
5655
Cov.:
36
AF XY:
0.0859
AC XY:
62320
AN XY:
725660
show subpopulations
Gnomad4 AFR exome
AF:
0.0146
Gnomad4 AMR exome
AF:
0.0608
Gnomad4 ASJ exome
AF:
0.121
Gnomad4 EAS exome
AF:
0.000252
Gnomad4 SAS exome
AF:
0.123
Gnomad4 FIN exome
AF:
0.0850
Gnomad4 NFE exome
AF:
0.0850
Gnomad4 OTH exome
AF:
0.0829
GnomAD4 genome
AF:
0.0665
AC:
10132
AN:
152260
Hom.:
419
Cov.:
33
AF XY:
0.0671
AC XY:
4999
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.0165
Gnomad4 AMR
AF:
0.0795
Gnomad4 ASJ
AF:
0.114
Gnomad4 EAS
AF:
0.00193
Gnomad4 SAS
AF:
0.122
Gnomad4 FIN
AF:
0.0809
Gnomad4 NFE
AF:
0.0904
Gnomad4 OTH
AF:
0.0833
Alfa
AF:
0.0825
Hom.:
323
Bravo
AF:
0.0610
Asia WGS
AF:
0.0450
AC:
156
AN:
3478
EpiCase
AF:
0.0951
EpiControl
AF:
0.0984

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 10, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
GenomeConnect, ClinGen
Significance: not provided
Review Status: no classification provided
Collection Method: phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Dyskeratosis congenita, autosomal recessive 5 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dyskeratosis congenita Benign:1
Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
17
DANN
Benign
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61753459; hg19: chr20-62321189; COSMIC: COSV58893451; COSMIC: COSV58893451; API